Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-18

Clinical Trial Update: Prasugrel Re-load Strategies [Phase 4]

View source ↗

Summary

Phase 4 study update shows completed prasugrel re-load strategy trial in coronary artery disease with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EFFIENT (prasugrel hydrochloride)

Snippet

Sponsor: University of Florida | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2013-01-18